Elixia launches cold chain logistics marketplace

IMT News Desk
IMT News Desk
· 2 min read

The platform optimises cold chain operations using best-in-class AI-driven technology

Elixia, a pioneering Logistics Tech SaaS AI Platform, has launched its groundbreaking cold chain logistics marketplace, transforming the way temperature-sensitive goods are transported across India. After the success of its dry cargo marketplace, Elixia is now redefining cold chain logistics by offering on-demand, temperature-controlled vehicle placement, ensuring efficiency, reliability, and real-time visibility for businesses.

The platform optimises cold chain operations using best-in-class AI-driven technology amalgamated with deep-seated industry expertise, significantly reducing wastage and improving supply chain efficiency, offering unparalleled value for all stakeholders.

Elixia’s cold chain marketplace – Elixia Connect – promises to streamline operations for more than 2,000 shippers and hundreds of transporters dealing with temperature-sensitive goods. By addressing the growing demand for reliable and efficient logistics solutions for products such as pharmaceuticals and other cold chain products, Elixia aims to set a new standard for cold chain logistics.

Sanket Sheth, Founder & President of Elixia, said, “This is a game-changer for India’s cold chain logistics. For too long, the industry has struggled with fragmented networks, unpredictable pricing, and limited vehicle availability. Our new marketplace directly addresses these challenges by providing a seamless, transparent, and cost-effective solution. By keeping the platform free for transporters and ensuring shippers only pay when they receive value, we are making cold chain logistics more efficient, accessible, and future-ready.”

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk